around
million
peopl
infect
worldwid
effect
vaccin
cur
therapi
hiv
remain
major
human
thread
better
understand
hiv
replic
cycl
viral
host
factor
involv
essenti
develop
new
therapi
option
yeastbas
studi
brought
light
key
aspect
function
three
hiv
protein
viral
protein
r
vpr
proteas
pr
regulatori
viral
protein
rev
vpr
protein
play
pivot
role
pathogenesi
involv
suppress
immun
function
deplet
infect
cell
final
lead
progress
aid
howev
mechan
underli
effect
pathogenesi
unknown
observ
initi
made
yeast
corrobor
mammalian
cell
demonstr
vpr
act
induc
arrest
cell
kill
induct
mitochondrialdepend
apoptosi
hiv
proteas
need
cleav
precursor
matur
protein
matrix
capsid
nucleocapsid
protein
studi
cerevisia
demonstr
pr
specif
arrest
cell
growth
induc
cell
lysi
mediat
loss
membran
integr
contribut
pr
hivinduc
necrosi
later
confirm
human
cell
line
prspecif
inhibitor
led
prevent
virusinduc
cell
lysi
result
highlight
import
prinhibitor
prevent
cell
loss
infect
final
rev
protein
play
essenti
role
hiv
replic
cycl
rev
mediat
export
unsplic
incomplet
splice
hiv
mrna
cytoplasm
thu
enabl
product
particl
import
find
show
rev
protein
mediat
export
hiv
premrna
interact
via
cisact
rev
respons
element
rre
context
spliceosom
first
shown
yeast
observ
led
identif
cerevisia
smallnucleoporinlik
protein
respons
cellular
compon
revmedi
export
protein
mediat
interact
rev
hcv
chronic
infect
million
peopl
worldwid
major
caus
liver
cirrhosi
hepatocarcinoma
spite
great
advanc
accomplish
sinc
identif
still
limit
therapi
option
vaccin
express
cerevisia
two
hcv
protein
nonstructur
protein
core
protein
togeth
construct
hcv
chimera
studi
hcv
rna
translat
made
yeast
valuabl
tool
hcv
research
yeast
human
cell
protein
predominantli
associ
er
membran
highli
conserv
amphiphat
alphahelix
nterminu
consist
propos
role
key
regul
membraneassoci
viral
replic
moreov
studi
yeast
human
cell
show
ntermin
truncat
mutant
transport
nucleu
due
function
nl
exhibit
transactiv
properti
interestingli
caspasemedi
cleavag
occur
apoptosi
interact
core
protein
infect
result
similar
truncat
transloc
nucleu
howev
way
transactiv
contribut
hcv
pathogenesi
still
remain
elucid
hcv
core
protein
interact
link
mani
process
hcv
patholog
mammalian
studi
known
hcv
core
protein
influenc
transcript
cellular
viral
promotor
howev
mechan
involv
mainli
unknown
studi
yeast
demonstr
effect
core
protein
transcript
factor
core
protein
process
yeast
mammalian
cell
local
nucleu
cytoplasm
transport
matur
core
protein
nucleu
shown
mediat
direct
interact
ortholog
human
importin
interact
turn
abrog
transport
transcript
factor
nucleu
consequ
contribut
regul
transcript
core
protein
bicistron
vector
recent
design
studi
hcv
rna
translat
yeast
hcv
rna
cap
thu
translat
depend
intern
ribosom
entri
site
ire
locat
region
ntr
hcv
iresmedi
translat
modifi
sever
viral
probabl
also
host
protein
bind
hcv
sinc
hcv
ire
function
yeast
bicistron
construct
gener
allow
fulli
explor
effect
viral
cellular
factor
hcv
translat
understand
fundament
step
viru
life
cycl
includ
virushost
interact
essenti
design
novel
effect
antivir
strategi
understand
hamper
complex
higher
eukaryot
host
organ
overcom
experiment
difficulti
system
develop
allow
replic
higher
eukaryot
virus
cerevisia
first
higher
eukaryot
viru
shown
replic
encapsid
genom
cerevisia
bromo
mosaic
viru
bmv
posit
strand
rna
rna
viru
plant
pioneer
work
open
new
avenu
viru
research
allow
appli
versatil
yeast
genet
tool
elucid
fundament
step
viru
replic
list
higher
eukaryot
virus
shown
replic
yeast
expand
ever
sinc
includ
virus
rna
genom
infect
plant
carnat
italian
ringspot
viru
cirv
tomato
bushi
stunt
viru
tbsv
cymbidium
ringspot
viru
cymrsv
anim
flock
hous
viru
fhv
nodamura
viru
nov
ii
virus
dna
genom
infect
human
human
papillomaviru
anim
bovin
papillomaviru
plant
mungbean
yellow
mosaic
india
viru
mymiv
importantli
yeast
system
reproduc
known
featur
viru
replic
correspond
natur
host
sinc
detail
descript
system
contribut
recent
review
highlight
main
achiev
viru
research
particular
focu
studi
carri
yeastrna
viru
system
sinc
advanc
rna
virus
shown
replic
yeast
belong
group
rna
virus
larg
viru
group
includ
mani
import
plant
anim
human
pathogen
hcv
sever
acut
respiratori
syndrom
coronaviru
sar
rna
virus
share
common
featur
replic
cycl
first
genom
rna
serv
messeng
rna
mrna
translat
viral
protein
templat
replic
sinc
two
function
mutual
exclus
transfer
genom
rna
cellular
translat
machineri
replic
complex
must
highli
regul
second
viral
replic
complex
associ
intracellular
host
membran
prolifer
rearrang
respons
express
viral
protein
third
host
factor
requir
multipl
step
viral
replic
cycl
yeast
rna
viru
system
develop
show
common
characterist
viral
rnadepend
rna
polymeras
rdrp
addit
protein
requir
viral
replic
express
tran
yeast
plasmid
ii
genom
rna
authent
end
also
transcrib
yeast
plasmid
transfect
directli
cell
iii
replic
monitor
detect
viral
rna
via
northern
blot
analysi
measur
express
report
gene
insert
viral
genom
express
depend
viral
rna
replic
fact
system
individu
viral
protein
given
tran
separ
plasmid
great
advantag
sinc
allow
simplifi
control
function
studi
player
viral
replic
import
aspect
viral
life
cycl
studi
like
translat
viral
protein
process
templat
select
format
replic
complex
viral
rna
replic
encapsid
recombin
review
detail
studi
result
impress
progress
understand
fundament
step
viral
rna
replic
viral
protein
involv
furthermor
due
common
replic
strategi
rna
virus
result
obtain
go
much
beyond
specif
viru
studi
identif
host
factor
involv
viral
rna
replic
prioriti
area
research
virolog
provid
new
target
antivir
drug
develop
use
tradit
yeast
genet
genomewid
screen
result
groundbreak
identif
multipl
host
factor
requir
viral
rna
replic
recombin
genedelet
mutant
collect
nonessenti
yeast
gene
delet
use
carri
genomewid
screen
host
factor
affect
replic
bmv
tbsv
bmv
studi
singl
delet
strain
transform
plasmid
express
bmv
replicas
polymeras
helicas
bmv
rna
replic
templat
harbour
luciferas
report
gene
express
screen
marker
bmv
rna
replic
tbsv
studi
similar
approach
appli
howev
effect
replic
follow
direct
visual
ethidiumbromidestain
gel
shorter
form
tbsv
rna
accumul
high
level
wildtyp
strain
analys
reveal
approxim
nonessenti
yeast
gene
analyz
around
found
affect
replic
viru
result
uncov
involv
viral
replic
previous
unconsid
cellular
pathway
mrna
turnov
stress
respons
ubiquitin
pathway
protein
degrad
surprisingli
previou
predict
gene
found
common
studi
discuss
possibl
relat
fact
bmv
tbsv
replic
associ
cellular
membran
differ
compart
spite
impress
achiev
identifi
essenti
host
facor
replic
mention
approach
limit
nonessenti
gene
screen
overcom
addit
genomewid
screen
perform
yeast
tet
promot
hugh
collect
ythc
tbsv
ythc
cover
essenti
gene
essenti
gene
control
tettitrat
promot
genom
way
express
essenti
gene
turn
addit
doxycyclin
yeast
growth
medium
approach
addit
cellular
gene
identifi
involv
replic
tbsv
tbsv
replic
yeast
also
undergo
recombin
elucid
eventu
role
host
factor
viral
rna
recombin
process
genomewid
screen
perform
yeast
collect
mention
sinc
recombin
nonrecombin
tbsv
form
vari
length
screen
perform
direct
visual
tbsv
rna
agaros
gel
combin
northern
blot
analysi
rtpcr
sequenc
genet
screen
identifi
nonessenti
essenti
gene
affect
tbsv
recombin
excit
observ
host
factor
influenc
viral
rna
recombin
therebi
evolut
brought
total
new
perspect
field
major
viral
pathogen
still
remain
without
effect
vaccin
therapi
option
thu
safer
effect
antivir
drug
urgent
need
improv
screen
process
enabl
assess
modeofact
test
compound
essenti
section
discuss
excit
contribut
yeast
genet
highthroughput
screen
drug
develop
present
first
princip
characterist
global
approach
applic
antivir
research
field
process
lead
discoveri
develop
new
drug
long
costli
two
approach
tradit
use
target
alreadi
known
drug
discoveri
search
classic
start
vitro
assay
identifi
small
molecul
inhibitor
assay
give
partial
view
effect
compound
sinc
instanc
fulli
explor
drug
effect
addit
target
sourc
undesir
side
effect
put
toxic
effect
test
subsequ
cell
cultur
anim
model
howev
toxic
detect
underli
mechan
still
unknown
ration
approach
possibl
modifi
drug
improv
safeti
altern
drug
discoveri
approach
directli
perform
cellbas
screen
molecul
produc
specif
desir
effect
advantag
molecul
encount
natur
physiolog
condit
allow
select
molecul
stabl
within
metabol
environ
discard
show
toxic
effect
howev
also
approach
exact
mechan
action
select
drug
remain
unknown
great
disadvantag
sinc
elucid
could
lead
design
new
compound
improv
safeti
efficaci
profil
approach
benefit
largescal
chemic
genet
tool
develop
cerevisia
allow
systemat
screen
put
target
effect
select
drug
sinc
effect
drug
everi
yeast
gene
analyz
broad
view
protein
relat
metabol
pathway
affect
accomplish
thu
includ
yeastbas
screen
earli
stage
drug
develop
programm
crucial
inform
rapidli
obtain
use
discard
improv
test
compound
largescal
chemic
genet
yeast
screen
use
mutant
strain
collect
gene
express
plasmid
describ
five
main
screen
approach
first
druginduc
haploinsuffici
approach
use
heterozyg
mutant
collect
base
find
reduc
copi
number
drug
target
gene
two
one
copi
significantli
sensit
diploid
cell
drug
second
approach
use
haploid
homozyg
diploid
delet
collect
base
principl
delet
gene
render
cellhypersensit
specif
drug
identifi
pathway
buffer
cell
toxic
effect
drug
thu
provid
clue
mode
action
third
approach
use
gene
express
librari
base
principl
increas
concentr
protein
target
inhibitori
drug
increas
resist
drug
three
approach
perform
two
differ
way
growth
measur
array
strain
ii
competit
grow
pool
strain
fourth
approach
base
gene
express
profil
consist
compar
chang
mrna
express
elicit
drug
interest
induc
drug
gene
delet
final
plasmid
collect
yeast
protein
express
gstfusion
use
creat
protein
chip
allow
screen
direct
drugprotein
interact
combin
five
power
techniqu
togeth
rapidli
grow
knowledg
yeast
genet
network
made
yeast
recogn
system
drug
develop
today
fulli
exploit
antivir
research
two
decad
search
antivir
drug
rather
limit
number
compound
market
almost
focu
hiv
herpesvirus
furthermor
antivir
cur
produc
major
side
effect
thu
urgent
need
novel
highqual
target
drug
togeth
improv
screen
system
identifi
two
kind
target
use
antivir
research
viral
factor
host
factor
classic
viral
protein
use
target
therapeut
intervent
develop
inhibitor
molecul
expect
produc
signific
side
effect
howev
seem
case
instanc
antiretrovir
current
avail
produc
import
side
effect
sinc
drugresist
mutant
rather
easili
select
research
shown
interest
host
factor
advantag
genet
stabl
may
even
effici
target
group
virus
mention
screen
option
could
help
select
host
factor
target
drug
lethal
viru
minor
effect
cell
two
yeast
cellbas
assay
establish
screen
viral
inhibitor
protein
influenza
viru
fundament
role
disassembl
influenza
virion
fact
commerci
avail
drug
target
protein
sinc
express
protein
yeast
produc
slower
growth
rate
screen
procedur
set
base
rescu
wt
cell
growth
presenc
test
compound
recent
parallel
approach
appli
serin
proteas
encod
human
cytomegaloviru
hcmv
proteas
essenti
viru
recogn
amino
acid
sequenc
insert
code
sequenc
yeast
enzym
involv
biosynthesi
tryptophan
coexpress
hcvm
proteas
engin
enzym
result
arrest
cell
growth
media
without
tryptophan
could
rescu
presenc
proteas
inhibitor
system
provid
basi
highthroughput
screen
inhibitori
molecul
relat
analysi
host
factor
antivir
target
genomewid
screen
yeastviru
system
describ
previou
section
provid
mani
new
candid
therapeut
potenti
remain
explor
studi
antivir
research
make
fulli
use
yeast
platform
tool
avail
innov
field
would
like
point
two
explor
mode
action
antivir
plu
therapeut
compound
first
studi
heterozygot
yeast
delet
collect
use
ass
cellular
effect
differ
compound
import
mention
construct
collect
yeast
gene
replac
cassett
contain
select
marker
gene
kanmx
plu
two
uniqu
tag
sequenc
locat
downstream
marker
gene
tag
sequenc
enabl
rapid
analysi
strain
pool
use
hybrid
highdens
nucleotid
array
importantli
tag
sequenc
flank
univers
primer
set
polymeras
chain
reaction
amplif
thu
pool
heterozyg
delet
strain
competit
grown
gener
media
contain
select
compound
dna
extract
cell
cultur
gener
amplifi
pcr
use
univers
primer
green
red
label
respect
amplifi
dna
hybrid
microarray
contain
specif
tag
sequenc
sinc
signal
intens
microarray
hybrid
proport
rel
tag
abund
pool
popul
yeast
strain
red
green
yellow
colour
array
correl
enrich
deplet
unchang
represent
strain
popul
way
effect
drug
yeast
delet
strain
could
rapidli
analyz
second
studi
complementari
approach
follow
yeast
haploid
delet
mutant
collect
test
hypersensit
differ
compound
includ
molecul
antivir
activ
sinc
consid
compound
similar
biolog
effect
lead
similar
chemic
profil
cluster
obtain
result
provid
use
data
set
allow
organ
compound
function
relev
group
result
obtain
studi
help
identifi
new
mode
action
test
compound
reveal
numer
insight
cellular
pathway
involv
yeast
util
vaccin
develop
classic
exampl
recombinantli
express
hepat
b
surfac
antigen
becom
safe
effici
prophylact
vaccin
worldwid
howev
section
focu
use
mere
product
tool
recombin
antigen
vaccin
vehicl
immun
bacteri
pathogen
virus
attract
strategi
combat
infecti
diseas
stimul
immun
system
tradit
vaccin
like
solubl
antigen
formul
adjuv
effici
activ
humor
immun
respons
product
neutral
antibodi
bind
invad
microorgan
inhibit
entri
target
cell
therebi
prevent
infect
howev
cellmedi
immun
humor
immun
alon
requir
control
infect
intracellular
pathogen
especi
virus
like
hiv
hcv
classic
view
cellular
immun
antigenpres
cell
apc
present
peptid
endogen
synthes
pathogen
protein
context
mhc
class
molecul
cell
surfac
antigenspecif
lymphocyt
becom
activ
recogn
peptid
subsequ
differenti
matur
effector
cell
popul
cytotox
cell
ctl
abl
recogn
kill
respect
infect
cell
addit
dendrit
cell
dc
potent
apc
use
mechan
crossprim
antigen
present
wherein
peptid
exogen
antigen
also
present
via
mhc
class
molecul
danger
signal
given
interact
pathogen
compon
eg
cell
wall
compon
yeast
pattern
recognit
receptor
surfac
apc
tolllik
receptor
tlr
mannos
glucan
receptor
lead
matur
apc
effici
antigen
present
whole
recombin
yeast
cell
known
target
molecular
immunogen
repres
novel
vaccin
tool
induct
potent
cellmedi
immun
respons
target
antigen
case
nonpathogen
baker
yeast
saccharomyc
cerevisia
use
antigen
carrier
genu
combin
sever
advantag
product
cerevisia
eg
bread
beer
consum
larg
amount
worldwid
healthi
individu
show
moder
cell
respons
cerevisia
probabl
due
mechan
oral
toler
import
primeboost
immun
strategi
observ
neutral
yeast
vector
host
immun
system
follow
multipl
immun
mice
rabbit
remark
low
titr
antiyeast
antibodi
found
repeat
inject
either
live
heatkil
antigenexpress
cerevisia
yeast
cell
potent
adjuv
effect
via
danger
signal
lead
matur
dc
without
danger
exogen
adjuv
need
facilit
particul
structur
yeast
antigen
effici
present
via
mhc
class
pathway
result
activ
antigenspecif
lymphocyt
stubb
et
al
show
first
time
recombin
yeast
express
antigen
tumour
antigen
potent
elicit
antigenspecif
ctl
respons
includ
mediat
tumour
protect
mice
studi
anim
tumour
challeng
model
could
demonstr
yeastbas
immunotherapi
use
mutat
ra
oncoprotein
target
antigen
caus
mutantselect
tumour
remiss
anim
concept
test
phase
clinic
trial
patient
colorect
pancreat
nonsmal
cell
lung
cancer
recent
group
evalu
recombin
yeast
cell
vaccin
express
hcv
fusion
protein
immunotherapeut
vaccin
chronic
hcvinfect
individu
one
advantag
use
whole
recombin
yeast
antigen
carrier
oral
applic
rout
feed
mice
cerevisia
express
actinobacillu
pleuropneumonia
antigen
led
induct
protect
system
mucos
immun
respons
fission
yeast
schizosaccharomyc
pomb
repres
like
cerevisia
physiolog
genet
well
character
eukaryot
use
africa
hundr
year
brew
millet
beer
first
isol
recombin
sz
pomb
cell
express
human
cytomegaloviru
protein
abl
stimul
memori
cell
human
blood
instead
use
recombin
yeast
express
antigen
choic
vaccin
attempt
made
express
mhc
protein
plu
desir
antigen
peptid
yeast
surfac
use
modifi
cell
kind
apc
brophi
colleagu
succeed
express
mous
mhc
protein
heavi
chain
plu
antigen
peptid
singl
gene
cassett
result
complex
assembl
function
conform
cell
surfac
even
induc
activ
cell
howev
whether
approach
practic
use
vaccin
yet
demonstr
strategi
use
yeast
cell
vaccin
could
also
use
elicit
protect
immun
respons
human
pathogen
yeast
exampl
genu
candida
abl
caus
varieti
infect
mucos
candidiasi
lifethreaten
dissemin
bloodstream
infect
especi
immunocompromis
individu
unfortun
interplay
protect
inhibitori
antibodi
dictat
outcom
experiment
dissemin
candidiasi
mice
receiv
heatinactiv
wholecel
c
albican
vaccin
observ
may
explain
subject
elev
anticandida
antibodi
titer
remain
nonetheless
suscept
invas
candidiasi
howev
ibrahim
colleagu
could
show
vaccin
recombin
ntermin
domain
adhesin
improv
surviv
murin
dissemin
candidiasi
enhanc
cellmedi
humor
immun
immunocompet
immunocompromis
mice
conclus
yeast
system
extrem
valuabl
viru
research
howev
full
potenti
remark
progress
system
yeast
biolog
last
year
yet
exploit
increas
option
analys
protein
interact
network
unpreced
level
complex
rise
number
viral
replic
system
yeast
correctli
mimic
fundament
properti
viru
life
cycl
higher
eukaryot
era
system
virolog
expect
becom
new
focu
viru
research
subsequ
better
understand
viru
proteinhost
cell
protein
interact
network
allow
search
develop
effici
safer
antivir
drug
moreov
acquir
inform
drug
function
molecular
level
help
search
new
drug
applic
might
significantli
reduc
time
frame
drug
develop
new
viru
appear
threaten
human
popul
author
declar
compet
interest
author
contribut
content
structur
present
review
